Cargando…
Management and Survival of Elderly and Very Elderly Patients with Ovarian Cancer: An Age-Stratified Study of 1123 Women from the FRANCOGYN Group
Elderly women with ovarian cancer are often undertreated due to a perception of frailty. We aimed to evaluate the management of young, elderly and very elderly patients and its impact on survival in a retrospective multicenter study of women with ovarian cancer between 2007 to 2015. We included 979...
Autores principales: | Joueidi, Yolaine, Dion, Ludivine, Bendifallah, Sofiane, Mimoun, Camille, Bricou, Alexandre, Nyangoh Timoh, Krystel, Collinet, Pierre, Touboul, Cyril, Ouldamer, Lobna, Azaïs, Henri, Dabi, Yohann, Akladios, Cherif, Canlorbe, Geoffroy, Bolze, Pierre-Adrien, Costaz, Hélène, Mezzadri, Mathieu, Gauthier, Tristan, Kridelka, Frederic, Chauvet, Pauline, Bourdel, Nicolas, Koskas, Martin, Carcopino, Xavier, Raimond, Emilie, Graesslin, Olivier, Lecointre, Lise, Ballester, Marcos, Huchon, Cyrille, Levêque, Jean, Lavoué, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290352/ https://www.ncbi.nlm.nih.gov/pubmed/32414065 http://dx.doi.org/10.3390/jcm9051451 |
Ejemplares similares
-
Ovarian Cancer in the Elderly: Time to Move towards a More Logical Approach to Improve Prognosis—A Study from the FRANCOGYN Group
por: Dion, Ludivine, et al.
Publicado: (2020) -
Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF()
por: Akladios, Cherif, et al.
Publicado: (2020) -
Prise en charge chirurgicale des cancers gynécologiques en période de pandémie COVID-19 – Recommandations du Groupe FRANCOGYN pour le CNGOF
por: Akladios, C., et al.
Publicado: (2020) -
Recurrence Pattern of Cervical Cancer Based on the Platinum Sensitivity Concept: A Multi-Institutional Study from the FRANCOGYN Group
por: de Foucher, Tiphaine, et al.
Publicado: (2020) -
Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group
por: Reboux, Pierre-Alain, et al.
Publicado: (2019)